Ghana vs Malta: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Ghana
97.0%
in 2025
Malta
97.0%
in 2025
Ghana rank
16th
Malta rank
16th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Ghana
- Malta
How they compare
Ghana currently reports 97.0% against 97.0% in Malta, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Malta ahead.
Ghana ranks 16th and Malta ranks 16th of 192 countries.
Ghana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 70.4% | 0.0% | 70.4% | Ghana |
| 2020s | 96.8% | 62.3% | 34.5% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Ghana or Malta?
- Ghana, at 97.0% against 97.0% in Malta as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Ghana and Malta?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Malta?
- 18 years are reported by both, from 2008 to 2025.
- How do Ghana and Malta rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Ghana ranks 16th and Malta ranks 16th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.